Background: We compared B-type natriuretic peptide (BNP) levels, clinical and laboratory findings in earlyonset preeclampsia (EOP), late-onset preeclampsia (LOP) and healthy pregnant groups. Methods: We studied 40 healthy pregnant and 40 preeclamptic patients. Preeclamptics were divided in two groups, the EOP group (n = 20) and LOP group (n = 20), according to gestational age at the onset of disease. The distinction criterion for early-vs. late-onset was set as week 34 of gestation. The concentration of the BNP levels was measured by a sandwich fluorescence immunoassay. For statistical analysis of the clinical and laboratory findings non-parametric methods were applied. Results: BNP levels were higher in EOP [61.35 (36.95-93.25) pg/mL] and LOP patients [32.4 (19.15-39.2) pg/mL] than in healthy pregnant women [10.05 (6.08-16.03) pg/mL] (both p < 0.001). Furthermore, EOPs had significantly higher BNP levels as compared to LOP patients (p < 0.001). A BNP cut-off < 24.5 pg/mL had a negative-predictive value of 85.1% excluding preeclampsia. There was a significant inverse correlation between plasma BNP levels of EOP patients and sodium (p < 0.05) and total protein concentrations (p < 0.05). In the EOP group, a significant positive correlation was observed between plasma levels of BNP and hematocrit (p < 0.05), serum potassium (p < 0.05), urea (p < 0.05) and 24-h proteinuria (p < 0.05). Conclusions: BNP levels were significantly higher in EOP than in LOP patients. The cut-off value < 24.5 pg/mL seems to be a powerful discriminative indicator excluding preeclampsia. The amount of proteinuria and total protein levels correlate with the elevation of the BNP levels. In EOP the extent of proteinuria is higher than in the LOP.
Introduction
Preeclampsia is a heterogeneous, multisystem disease in human pregnancy with a worldwide incidence of 2%-10%. It is one of the leading causes of maternal and perinatal morbidity and mortality [1, 2] . Even after the delivery patients with a history of preeclampsia are at elevated risk to develop cardiovascular disease in later life [3] . Normal pregnancy represents a state of physiologic volume expansion. Maternal blood volume increases about 40% above the prepregnancy volume. Plasma osmolality is reduced, due to mild hyponatremia despite sodium retention. In normal pregnancies B-type natriuretic peptide (BNP) levels are stable at low values in all trimesters and at delivery [4, 5] . Increased natriuretic peptide levels are associated with cardiovascular morbidity during pregnancy [6] . BNP level seems to be a powerful marker particularly for severe preeclampsia [4] . Ethnicity does not influence this connection [7] .
The subclassification of preeclampsia on the basis of gestational age at disease onset divide early-onset (EOP) (before 34th gestational week) and late-onset preeclampsia (LOP) [8, 9] . These two subgroups seem to have different etiologies and they are widely believed as different forms of the disease. EOP is associated with placental histopathological differences, intrauterine growth restriction, increased total vascular resistance, hypovolemia and adverse maternal and neonatal outcomes [10, 11] . Higher proteinuria is associated with EOP [12] . However, LOP is accompanied with increased body mass index (BMI), normal or slight elevated uterine resistance index and a low rate of intrauterine growth restriction [13] . Preeclampsia may be a common endpoint of, at least two distinct pathophysiologic processes. Although enhanced levels of BNP were shown in preeclampsia compared with healthy pregnancy no previous study has examined whether BNP levels show difference between EOP vs. LOP patients. In this study we compared the circulating levels of BNP, standard clinical chemistry levels in patients with EOP and LOP with those found in healthy pregnant women.
Materials and methods

Study population
All pregnant women who were admitted to the First Department of Obstetrics and Gynecology of Semmelweis University Budapest, Hungary from the 1 January 2008 to 31 December 2010 were screened for participation. The total number of deliveries during this period was 11,154 deliveries, about 3,700 deliveries/year. Three hundred and fifty-two pregnant women with diagnosis of preeclampsia delivered in this period at our clinic, approximately 3.2% of all deliveries. Preeclampsia was defined according to the ACOG guidelines by increased blood pressure ( ≥ 140 mm Hg systolic or ≥ 90 mm Hg diastolic on ≥ 2 occasions at least 6 h apart) that occurs after the 20th week of gestation in a woman with previously normal blood pressure, accompanied by proteinuria ( ≥ 0.3 g/24 h in the absence of urinary tract infection) [14] . Preeclamptic patients' blood samples were collected at the time of their initial assessment for preeclampsia, before cristalloid infusion, magnesium sulfate or antihypertensive therapy was administered, or uterine contractions started.
In the examined period 72 pregnant women started the symptoms before the 34th week, approximately 20.5% of all preeclamptic patients. One hundred and eighty-five patients of the 352 fulfilled the inclusion criteria. The majority of the excluded did not have a 24-h urine collection or they had incomplete or irretrievable charts. Of the remaining patients 145 were excluded on the following exclusion criteria: chronic hypertension, multifetal gestation, renal disorder, autoimmune disease, angiopathy, maternal or fetal infection and fetal congenital anomaly.
The preeclamptic patients (n = 40) were divided into EOP (n = 20) and LOP (n = 20) subgroup depending on the gestational age at the diagnosis of preeclampsia. EOP was defined as onset of the disease before the 34th week of gestation (between the 20th and 33rd completed gestational weeks). All of these patients delivered before the 34th week of gestation.
The control group was recruited from healthy women with normal pregnancy that delivered during the same time period. Patients were excluded from the control group if they developed hypertensive disorder. The normal pregnancy group (n = 40), matched the preeclampsia group with age, prepregnancy BMI and smoking habits. There was no significant difference between the preeclamptic patients and healthy controls in the blood storage times. Informed consent was obtained and blood samples were collected in the third trimester. None of the pregnant women had rupture of membranes. Mothers recruited in both groups were Caucasians and resided in the same geographic area in Hungary.
Intrauterine growth retardation (IUGR) was declared with a birth weight below the 10th percentile of that anticipated for gestational age. The customized centile calculator of the Hungarian Obstetrician Association was used to derive the growth centile of each infant in the study [15] . Gestational age was established by a first trimester dating ultrasound scan for all the women.
The Ethical Committee of the Semmelweis University approved and registered the study, all participants were informed and they agreed to their involvement in the study. Written informed consent was obtained from each patient.
Biochemical markers
Blood samples were taken from an antecubital vein into plain and EDTA tubes and then centrifuged at room temperature with a relative centrifugal force of 3000 g for 10 min. The aliquots of serum and plasma were stored at −80°C until the analyses. We analyzed the patients' laboratory findings (complete blood count, renal function, serum electrolytes, 24-h urine). Standard laboratory parameters (clinical chemistry levels) were determined by an autoanalyzer, using the manufacturer's kits in the Central Laboratory of the Semmelweis University. All data were collected from the medical records of the patients. Blood count was determined with Advia 120 Hematology System (Advia Centaur BNP, Siemens Healthcare Diagnostics, Tarry Town, NY, USA) and urea, serum electrolytes and total protein and 24-h urine protein amount with Beckman Coulter AU5800 System (Beckman Coulter, Inc., Brea, CA, USA). Creatinine was measured with automated analyzers using the non-enzymatic, kinetic Jaffe's method.
Measurement of B-type natriuretic peptide levels
The concentration of the BNP levels were measured by immune fluorescence method using 250 µL EDTA plasma from 40 preeclamptic patients and 40 healthy controls (Triage BNB test, Biosite Diagnostics Incorporated, San Diego, CA, USA). The Triage BNP test is a sandwich fluorescence immunoassay, comprising the Triage Meter and a disposable, single-use, plastic assay cartridge. It employs standard immunoassay techniques using recombinant murine antibodies to specifically and quantitatively detect the target protein, BNP, in EDTA-anticoagulated plasma specimens. Quantitative measurements of BNP concentration in the range from 5 to 5000 pg/mL are displayed on the meter screen and/or printout in approximately 15-20 min. Values outside of this range are set to their respective range limits for analysis (e.g., any result < 5 pg/mL is set to 5 pg/mL and any result > 5000 pg/mL is set to 5000 pg/mL). EDTA plasma samples were first thawed by placing the samples in a water bath at 21 ± 3°C for 30-60 min. Before inoculation of the sample onto the cartridge, samples were mixed by gently inverting the sample tubes for approximately 3 s. Samples were added using a transfer pipette and the inoculated assay cartridge was then placed into the Triage Meter. The Triage Meter automatically monitors progression of the immunoassay and reports the BNP concentration on completion of the assay. The analytic sensitivity, precision and stability of the test have been previously described. The test showed coefficients of variation of 8.8%-11.6% intra-assay imprecision and 9.9%-12.2% total imprecision at 71.3-4087.9 pg/mL [16] [17] [18] [19] .
Statistical analysis
The normality of continuous variables was assessed using the Shapiro-Wilk's W-test. As the continuous variables were not normally distributed, non-parametric statistical methods were used. To compare continuous variables between two groups, the Mann-Whitney Utest was applied, whereas to compare them among multiple groups, the Kruskal-Wallis analysis of variance by ranks test was performed. Multiple comparisons of mean ranks for all groups were carried out as post-hoc tests. The Pearson's χ 2 -tests were used to compare categorical variables between groups. The Spearman's rank order correlation was applied to calculate correlation coefficients. For all statistical analyses p < 0.05 was considered statistically significant. Finally, we constructed receiver operating characteristic (ROC) curves to illustrate the best cut-off value of BNP between the preeclamptic and healthy pregnant women.
In the article, data are reported as median (interquartile range) for continuous variables and as number (percentage) for categorical variables.
Results
The clinical characteristics of the participants are described in Table 1 . There was no significant difference in terms of maternal age, prepregnancy BMI and smoking habits. However, other clinical features differed significantly among our study groups. The rate of primiparity was higher, while neonatal birth weight was lower in both EOP and LOP groups to the healthy pregnant women. In the EOP group frequency of intrauterine growth restriction was significantly higher compared to LOPs and healthy controls. We observed no difference between EOP and LOP patients in terms of systolic or diastolic blood pressure.
The laboratory parameters of the study subjects are displayed in Table 2 . There were significant differences in Table 1 Clinical characteristics of healthy pregnant women and preeclamptic patients.
Early onset preeclamptics
Late onset preeclamptics Controls n = 20 n = 20 n = 40 most of the measured parameters among the three study groups except for white blood cell (WBC), platelet count (Plt) and serum chloride levels. Hemoglobin values were significantly higher, while serum sodium levels significantly lower in EOP patients than in the healthy pregnant women and in the LOP groups. Hematocrit and serum potassium, urea, uric acid levels were significantly higher and the total protein levels significantly lower in EOP and LOP patients than in healthy pregnant women. Furthermore, EOPs had significantly higher 24-h proteinuria values as compared to LOP patients.
In the preeclamptic group we found a significant inverse correlation between gestational age at disease onset and plasma BNP levels (R = −0.56, p < 0.001). In the control group there was no correlation between gestational age at blood collection and plasma BNP levels.
As shown in Figure 1 , plasma BNP levels were higher in EOP [61. 35 (36. mL]. These differences were highly significant (both p < 0.001). Furthermore, EOPs had significantly higher BNP levels as compared to LOP patients (p < 0.001).
We also investigated whether plasma BNP levels of the study participants were related to their clinical features or laboratory parameters by calculating the Spearman's rank order correlation coefficients. In the group of healthy pregnant women serum BNP concentrations correlated significantly negatively with serum total protein levels and platelet count (R = −0.33 and −0.37, respectively p < 0.05 for both) and positively with systolic and diastolic blood pressure (R = 0.31 and 0.32, p < 0.05 for both). In LOP patients also systolic and diastolic blood pressure (R = 0.64, p < 0.05 and R = 0.83, p < 0.001) and 24-h proteinuria (R = 0.48, p < 0.05) correlated significantly with BNP levels. There was a significant inverse correlation between plasma BNP levels of EOP patients and sodium (R = −0.6, p < 0.05) and total protein concentrations (R = −0.58, p < 0.05). In the EOP group, a significant positive correlation was observed between plasma levels of BNP and hematocrit (R = 0.59, p < 0.05), serum potassium (R = 0.66, p < 0.05), urea (R = 0.59, p < 0.05) and 24-h proteinuria (R = 0.62, p < 0.05).
We have investigated the added value of maternal available clinical markers (BMI, maternal age) but we did not find any relationship.
Using the ROC curve analysis (Figure 2 ) we determined the best cut-off value to be 24.5 pg/mL for plasma BNP concentration based on the closest to the 100% sensitivity and 100% specificity, discriminate EOP patients from healthy pregnant women [sensitivity: 95% specificity: 97.5%; area under curve (AUC) with 95% CI 0.98 (0.91-0.99) p < 0.001]. The same cut-off value by LOP patients (Figure 3) , yielding a sensitivity of 70% specificity: 97.5%; AUC with 95% CI 0.88 (0.77-0.95) p < 0.001. A BNP cut-off < 24.5 pg/mL had a negative-predictive value of 85.1% in excluding preeclampsia.
Discussion
This is the first study to assess the plasma levels of BNP in patients with EOP, LOP and healthy pregnant women. Our study demonstrates several important findings. First we found that preeclamptic patients with onset of the disease before 34th gestational week had BNP values that were significantly higher compared with both the healthy pregnant study participants and the group with LOP. Recently, Resnik et al. found that severe preeclamptic patients had higher BNP levels than those with mild preeclampsia. They found the 40 pg/mL cut-off value with AUC 0.86 (95% CI 0.76-0.95) independently of the severity of the disease. Hamad et al. used NT-pro-BNP to assess left ventricular function in preeclampsia [20] . They found in severe, earlyonset patients higher NT-pro-BNP levels than in patients with onset of the disease after 34th gestational week. The second major finding of this study is that BNP levels correlates positively with quantity of proteinuria in preeclamptic patients and inversely with total protein levels in both healthy and preeclamptic pregnant women. In EOP the amount of proteinuria is higher than in the late-onset case of the disease. It is very interesting that in the group of EOP patients the serum sodium levels are significantly lower and potassium levels higher than in healthy pregnant women. These findings supporting the theory that BNP's renal and extrarenal effects influence together with the enhanced hypovolemia the pathophysiology of preeclampsia.
In preeclampsia renal hemodynamics decreases and urinary protein excretion increases, in part due to lesions affecting the glomerulus. "Glomerular endotheliosis" represents a specific variant of thrombotic microangiopathy that is characterized by glomerular endothelial swelling with loss of endothelial fenestrae and occlusion of the capillary lumens [21] . Microalbuminuria defined as a urine albumin excretion between 30 and 300 mg/24 h, is a specific, glomerular subform of proteinuria. Microalbuminuria is an independent predictor of progressive renal disease and cardiovascular mortality was evaluated in patients with diabetes mellitus and hypertension [22, 23] . Microalbuminuria arises from increased leakage of albumin through the glomerular filtration barrier [24] . Renal dysfunction is a confounder for increased natriuretic peptide concentrations in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies [25] . BNP provides information regarding risk for incident of chronic kidney disease and microalbuminuria [26] . In asymptomatic type 2 diabetes patients BNP is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass [27] . Onodera et al. found plasma BNP levels more useful for cardiovascular risk assessment in diabetes mellitus patients compared to albuminuria [28] . Meanwhile, Leeuw et al. found in patients with severe burns, that increased BNP level together with decreased proteinuria is associated with a better outcome. It might reflect a decreased capillary leakage [29] .
Increasing hypoproteinemia leads to hyposmotic conditions in the vasculature and water diffuses extravascularly to the interstitium, which causes not only edema, but hypovolemia. Hypovolemia leads to decreased ventricular preload, which in turn reduces the stroke volume. In addition to these pathophysiological processes plasma fluid losses are accompanied by (endothelial) injury-induced inflammatory responses, which contributes to the secondary microcirculatory injury.
The decreased cardiac output in preeclamptic patients leads to production of the vasoconstrictor arginine vasopressin (AVP) from the posterior pituitary. AVP increases the permeability of the renal collecting ducts, leading to the reabsorption of free water. Afferent signals to the CNS can also activate the efferent sympathetic nervous system pathways. In preeclampsia sympathetic overactivity was suggested by elevated norepinephrine levels and plasma renin activity effect of changes in body posture in the upright position [30] . The increase in sympathetic activity is associated with collapse of venous capacitance vessels. In formerly preeclamptic women sympathoinhibitory response to volume expansion is diminished in low plasma volume, which suggests that cardiovascular reflex function is impaired [31] .
A reduction in myocardial compliance is frequent, reducing ventricular end diastolic volume and hence stroke volume at any given ventricular filling pressure. Restoration of intravascular volume may return stroke volume to normal but only at elevated filling pressures. Increased filling pressures stimulate the cardiac myocytes in the ventricles to release BNP. Borghi et al. found with echocardiographic examination in preeclamptic patients significant increases in left ventricular mass and left ventricular end systolic and end diastolic volumes and significant reductions in left ventricular ejection fraction and percentage of fractional shortening. BNP levels were linearly related to the left ventricular structural and functional changes observed in patients with preeclampsia [32] . The effect of BNP is secreting sodium and volume to relieve the pressure to the heart, but it worsens hypovolemia.
Sympathethic stimulation of the kidney leads to the release of renin, with a resultant increase in the circulating levels of angiotensin II and aldosterone. The activation of the renin-angiotensin-aldosterone system promotes salt and water retention and leads to vasoconstriction of peripheral vasculature, myocyte hypertrophy, myocyte death and myocardial fibrosis [33, 34] . It is interesting that cardiological patients with decreased cardiac output and hyponatremia have notably higher plasma renin activity, aldosterone and BNP levels than those patients without hyponatremia [35] .
BNP production is also demonstrated in many cell types. In particular, hypoxia induces extracardiac BNP expression. EOP is associated with more placental histopathological differences and increased total vascular resistance leading to local hypoxia than late-onset form of the disease [10, 36] . BNP shows paracrine actions not only in the heart but in the placenta and in many tissues [37] . BNP modulating the neighboring cells on endothelial proliferation and tissue remodeling [38] . BNP production could be not only an adaptation to the increase in systemic blood pressure but a consequence and defence mechanism of the placental hypoxia. Elevated plasma BNP levels in EOP support the theory that early-onset and late-onset forms of the preeclampsia have two different pathophysiological origins.
Placental ischemia in preeclampsia leads to endothelial exaggerated activation and a generalized hyperinflammatory condition [2] . One of the results of this process is the enhanced formation of endothelin-1 [39] [40] [41] [42] . Endothelin-1 has not only a potent systemic vasoconstrictor effect, but stimulates natriuretic peptide synthesis. BNP also reduces renin-angiotensin-aldosteron activities and inhibits endothelin-1 production.
A limitation of our study was the relative small number of the cases. This was due to the strict selection of the patients. Our clinic is a tertiary referral center. Significant number of the patients sent from other hospitals already started with an antihypertensive treatment. The rest of the excluded preeclamptic patients delivered in the first 24 h after the admission without urine collection. Our selection of the patients may modify also the discriminative power of the found cut-off value excluding preeclampsia. Further studies are required to increase reliability. Another type of limitation our study was that not only kidney and the heart were regulating homeostasis. Also perspiration, respiration and the fluid transmission through the digestive system influenced isovolemia and isoionia. All measurements were performed under controlled environmental conditions. Fasting blood samples were taken at the morning in the same laboratory room with constant 21°C ambient temperature. The Triage BNP test has also some limitations. There are significant differences in the analytical characteristics among the various methods for BNP and NT-pro-BNP. The agreement between NT-pro-BNP methods is better than among the BNP immunoassays [18, 43, 44] . NT-pro-BNP, however, is a hormonally inactive peptide and have six-fold longer half-life than BNP. The major clearance mechanism opposite to natriuretic peptide receptors for BNP is the renal clearance for NT-pro-BNP.
In conclusion our results show that plasma BNP levels were higher in EOP than in LOP patients. Amount of proteinuria and total proteins levels correlate with the elevation of the BNP levels. In EOP the extent of proteinuria is higher than in the late-onset case of the disease. This is probably due to a trend for more severe form of the disease in the EOP compared to LOP. Further larger studies are required to unfold the connection between the physiological processes and the pathological complications in preeclampsia.
